
A recent case series reviewed the treatment patterns and effects of therapies on 89 pediatric patients with CCD.

A recent case series reviewed the treatment patterns and effects of therapies on 89 pediatric patients with CCD.

TMB-001 0.05% demonstrates promising efficacy and safety in treating moderate to severe congenital ichthyosis, according to a poster presented at the SPD's annual meeting.

Preoperative pain and anticipated postoperative pain were found to predict postoperative pain in patients undergoing dermatologic surgery.

Explore dermatology's history and the journey through our publication's 45 years of covering an ever evolving specialty.

July 8th has been established as World Skin Health Day, with celebrations planned and anticipated on a global scale.

Keep up with the latest headlines in dermatology from the past week, including the appointment of the Canadian Dermatology Association's new president, a program aimed at supporting diverse, aspiring dermatologists, and more.

In case you missed it, this week we had news about the FDA's approval of biosimilar ustekinumab-ttwe, addressing acne scarring concerns, the intersection of permanent makeup and dermatology, and more.

Dermatology Times' Summer Editor in Chief, Shanna Miranti, MPAS, PA-C, shares how she has learned to be happy, stay humble, and be brilliant in her more than 22 years in dermatology.

Shahriari spoke about the importance of comprehensive care, collaborating with other specialists, and addressing psychosocial impact.

The first issue of Dermatology Times was published in 1979 to offer clinical insights into a growing health care specialty.

As many as 76.5% of participants could not name any psychodermatology resources, while only 58.8% were definitively interested in training on the topic.

Explore evidence-based clinical recommendations for fireworks burns, chlorine irritation, and more.

A recent review found success from a 3-component, simplified habit reversal therapy implemented by dermatologists for BFRBs.

Keep up with the latest headlines in dermatology from the past week, including application of AI in dermatology, exposure to forever chemicals through the skin, and more.

Dermatology Times is looking back on the top stories in dermatology from the month of June.

Dermatology Times is recapping our top expert interviews from the month of June.

Recent research has shed light on public interest of BPO utilizing relative search volume data.

Keep up with the latest headlines in dermatology from the past week, including a first-of-its-kind study linking psoriasis and OCD, DermTech's Chapter 11 bankruptcy filing, and more.

Botanix Pharmaceuticals announced the approval of its sofpironium topical gel, 12.45% for adults and children ages 9 and older.

LC-OCT non-invasively assessed non-structural changes from botulinum toxin and irreversible tissue changes from microwave thermolysis in hyperhidrosis.

BPO may prevent post-operative infections with limited risk of microbial resistance in surgery of sebaceous areas, according to a new study.

The authorization of DermaSensor marks a milestone in AI-enabled devices, highlighting opportunities and challenges in their integration into clinical practice.

Perceived stress, however, did not exhibit any correlations with psycho- and skin physiological parameters.

Laura Bush reflects on her term as SDPA president, discussing achievements, challenges, and the future of dermatology PAs in health care.

Rob Casquejo, PA-C, spoke with Dermatology Times on new and upcoming medications, addressing unmet needs, and social media misinformation.